CLDX 25.60 ▲ 5.65% Live Trading Data - Stocknear

Celldex Therapeutics Inc.

NASDAQ: CLDX · Real-Time Price · USD
25.60
1.37 (5.65%)
At close: Sep 24, 2025, 3:59 PM
25.79
0.74%
After-hours: Sep 24, 2025, 06:57 PM EDT
5.65%
Bid 23.6
Market Cap 1.7B
Revenue (ttm) 5.79M
Net Income (ttm) -199.61M
EPS (ttm) -3.01
PE Ratio (ttm) -8.5
Forward PE -5.99
Analyst Buy
Dividends n/a
Ask 26.82
Volume 1,174,206
Avg. Volume (20D) 1,264,323
Open 24.22
Previous Close 24.23
Day's Range 24.05 - 25.62
52-Week Range 14.40 - 47.00
Beta 1.19
Ex-Dividend Date n/a

About CLDX

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CLDX
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for CLDX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
Celldex Therapeutics Inc. is scheduled to release its earnings on Nov 5, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-13.03%
Celldex Therapeutics shares are trading lower afte... Unlock content with Pro Subscription
1 month ago
-1.88%
Celldex Therapeutics shares are trading lower. The company reported Phase 2 topline results for Barzolvolimab in Eosinophilic Esophagitis.